Cargando…
Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061287/ https://www.ncbi.nlm.nih.gov/pubmed/35091659 http://dx.doi.org/10.1038/s41375-021-01501-0 |
| _version_ | 1784698698002857984 |
|---|---|
| author | Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji |
| author_facet | Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji |
| author_sort | Abdallah, Nadine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9061287 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90612872022-05-04 Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji Leukemia Letter Nature Publishing Group UK 2022-01-29 2022 /pmc/articles/PMC9061287/ /pubmed/35091659 http://dx.doi.org/10.1038/s41375-021-01501-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title | Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_full | Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_fullStr | Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_full_unstemmed | Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_short | Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_sort | tracking daratumumab clearance using mass spectrometry: implications on m protein monitoring and reusing daratumumab |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061287/ https://www.ncbi.nlm.nih.gov/pubmed/35091659 http://dx.doi.org/10.1038/s41375-021-01501-0 |
| work_keys_str_mv | AT abdallahnadine trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT murraydavid trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT dispenzieriangela trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kapoorprashant trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT gertzmoriea trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT lacymarthaq trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT haymansuzanner trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT buadifrancisk trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT gonsalveswilson trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT muchtareli trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT leungnelson trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT dinglidavid trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kourelistaxiarchis trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT warsamerahma trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT bindermoritz trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kyleroberta trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT rajkumarsvincent trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kumarshaji trackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab |